Literature DB >> 2438845

Clonal selection of human immunodeficiency virus (HIV): serological differences in the envelope antigens of the cloned viruses and HIV prototypes (HTLV-III B, LAV, and ARV).

S Harada, N Kobayashi, Y Koyanagi, N Yamamoto.   

Abstract

Human T-cell lymphotropic virus type III B (HTLV-III B) derived from H9/HTLV-III cells was cloned by a plaque-forming assay. Cloned viruses showed different restriction cleavage patterns, suggesting that HTLV-III B is a mixture of several viruses. Using two different neutralization assay systems, we compared the envelope antigenicity of uncloned HTLV-III B, cloned viruses, lymphadenopathy-associated virus (LAV), and acquired immune deficiency syndrome (AIDS)-associated retrovirus (ARV). A diversity of viral envelope antigens was consistently found among the strains of these AIDS-related retroviruses. These results concur with the previous finding that genomic divergence of AIDS-related viruses is located mainly in the region of the viral envelope gene. Thus, this plaque assay is useful for the clonal analysis of the virus, which is essential for comparing the envelope antigen(s) of the virus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2438845     DOI: 10.1016/0042-6822(87)90219-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Abrogation of in vitro suppression of human immunodeficiency virus type 1 (HIV-1) replication mediated by CD8+ T lymphocytes of asymptomatic HIV-1 carriers by staphylococcal enterotoxin B and phorbol esters through induction of tumor necrosis factor alpha.

Authors:  M Kubo; T Ohashi; M Fujii; S Oka; A Iwamoto; S Harada; M Kannagi
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Characterization of human T-cell lines harboring defective human immunodeficiency virus type 1.

Authors:  Y Hamamoto; K Takamatsu; S Kobayashi; K Yamaguchi; N Yamamoto; N Kobayashi
Journal:  Virus Genes       Date:  1989-11       Impact factor: 2.332

3.  Investigating the presence of HIV sequences and the distribution of virological markers in hemophiliacs and their sexual partners.

Authors:  M da S Cardoso; S Epple; K Koerner; B Kubanek; D Ellbrück; E Seifried
Journal:  Ann Hematol       Date:  1991-12       Impact factor: 3.673

4.  Allo-antigen stimulated CD8+ T-cells suppress NF-κB and Ets-1 DNA binding activity, and inhibit phosphorylated NF-κB p65 nuclear localization in CD4+ T-cells.

Authors:  Ryuichi Nagashima; Fumitaka Kawakami; Shinichiro Takahashi; Fumiya Obata; Makoto Kubo
Journal:  Viral Immunol       Date:  2014-05-20       Impact factor: 2.257

5.  Activation of NFAT-dependent gene expression by Nef: conservation among divergent Nef alleles, dependence on SH3 binding and membrane association, and cooperation with protein kinase C-theta.

Authors:  A Manninen; P Huotari; M Hiipakka; G H Renkema; K Saksela
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

6.  Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies.

Authors:  P L Nara; W G Robey; S W Pyle; W C Hatch; N M Dunlop; J W Bess; J C Kelliher; L O Arthur; P J Fischinger
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

7.  Analysis of 3' terminals of human immunodeficiency virus type 1 transcripts in persistently infected cells.

Authors:  T Masuda; M A el-Farrash; M J Kuroda; S Harada
Journal:  Virus Genes       Date:  1993-09       Impact factor: 2.332

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.